$2.40
-0.02-0.83%
At close: -
Comments
Loading...
iBio (AMEX:IBIO) Stock Quotes, Forecast and News Summary
iBio Stock (AMEX: IBIO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy iBio (IBIO) stock?
You can purchase shares of iBio (AMEX:IBIO) through any online brokerage.
Who are iBio (IBIO) competitors?
Other companies in iBio’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Curis (NASDAQ:CRIS), Nanoviricides (AMEX:NNVC) and Bolt Biotherapeutics (NASDAQ:BOLT).
What is the forecast, or price target, for iBio (IBIO) stock?
iBio has a consensus price target of $3.69.
What is the current price for iBio (IBIO)?
The stock price for iBio (AMEX: IBIO) is $2.45 last updated December 18, 2024 at 4:49 PM EST.
Does iBio (IBIO) pay a dividend?
There are no upcoming dividends for iBio.
When is iBio (AMEX:IBIO) reporting earnings?
iBio’s Q2 earnings are confirmed for Friday, February 7, 2025.
Is iBio (IBIO) going to split?
There is no upcoming split for iBio.
What sector and industry does iBio (IBIO) operate in?
iBio is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.